OC Oerlikon Corporation AG (0QO3)
London Exchange · UK · prices in CHF · close of 19 Oct 2026
Key indicators
| Last close | CHF 5.825 |
|---|---|
| 52-week range | 2.572 – 6.000 |
| Return, 1 month / 3 months | +7.8% / +23.9% |
| Return, 1 year / 3 years | +123.8% / +76.8% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 39.8% |
| Worst drawdown (1 year) | -28.5% |
| Average daily value traded | 0.50M CHF |
| Dividend yield | 3.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
OC Oerlikon Corporation is a Swiss industrial technology group based in Pfäffikon. It supplies surface engineering and materials solutions, including coatings, thin-film production equipment and advanced materials, along with polymer processing and additive manufacturing machinery and components. Its customers are manufacturers across industries such as automotive, aerospace, tooling, energy and general industrial production, who use its equipment and coatings to improve the performance and durability of their products and components.
On this site OC Oerlikon Corporation AG appears as a stock on the London Exchange (UK), code 0QO3, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
OC Oerlikon Corporation AG (0QO3) trades on the London Exchange in UK. It last closed at CHF 5.825 on 19 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 443 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 123.8% and over the last three months it rose 23.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 93 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 39.3% | ||
| From 52-week high | -2.3% | ||
| Momentum | 95 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 23.9% | ||
| 6-month return | 76.8% | ||
| 12-month return, skipping the last month | 107.7% | ||
| Risk (lower is better) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 39.8% | ||
| Worst drawdown (1 year) | -28.5% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.50M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 58 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Risk (lower is better): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | +7.8% |
| 3 months | +23.9% |
| 6 months | +76.8% |
| 1 year | +123.8% |
| 3 years | +76.8% |
| 5 years | – |
Signals
| 50-day / 200-day average | 5.407 / 4.183 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.171 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | CHF 0.2000 |
| 3 Apr 2025 | CHF 0.2000 |
| 25 Mar 2024 | CHF 0.2000 |
| 23 Mar 2023 | CHF 0.3500 |
| 7 Apr 2022 | CHF 0.3500 |
| 15 Apr 2021 | CHF 0.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.